New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Eli Lilly and Company

LLY

Healthcare Drug Manufacturers General

Eli Lilly and Company’s revenue for fiscal 2025 (year ended December 2025) was $65.2 billion, up 44.7% from fiscal 2024.

Revenue
+38.6%
EPS
+16.3%
Free cash flow
+21.8%
Total debt
+15.0%

Quarter to September 2026, against a year earlier

1,355.43 3.78 +0.28%
Market cap
$1.27T
P/E
43.9×
Fwd P/E FY26e
42.2×
Dividend yield
0.51%
F-score
7/9
ROIC
26.4%
Net debt / EBITDA
1.2×
Payout ratio
0.2×

Eli Lilly and Company (LLY) EV/EBITDA

Alert me on EV/EBITDA

As of Nov 19, 2026, Eli Lilly and Company (LLY) trades at a EV/EBITDA of 33.9×. Over the past ten years it has ranged from 16.9× (December 2016) to 93.6× (October 2024); the current reading is higher than 71% of that period. That is above the Drug Manufacturers General industry median of 13.9× and above the Healthcare sector median of 8.5×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 35.3× (28.22%)
FY2024 49.2× (28.67%)
FY2023 69.0× 73.88%
FY2022 39.7× 19.01%
FY2021 33.3× 48.09%
FY2020 22.5× 3.21%
FY2019 21.8× (7.08%)
FY2018 23.5× (7.91%)
FY2017 25.5× 49.17%
FY2016 17.1× (24.37%)

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 29.2× (6.44%)
Jun 2026 31.2× 22.15%
Mar 2026 25.6× (27.59%)
Dec 2025 35.3× 21.99%
43 more quarters

Against its own ten years

Low 16.9× High 93.6×
Ten-year median 26.9×
Current reading's percentile 71

EV/EBITDA against peers

Company EV/EBITDA
PFE Pfizer Inc. compare 10.2×
AZN AstraZeneca PLC compare 13.9×
NVS Novartis AG compare 14.6×
AMGN Amgen Inc. compare 16.2×
ABBV AbbVie Inc. compare 19.8×
JNJ Johnson & Johnson compare 23.9×
MRK Merck & Co., Inc. compare 27.1×
LLY Eli Lilly and Company 33.9×
GILD Gilead Sciences, Inc. compare 502×
Drug Manufacturers General industry median 13.9×
Healthcare sector median 8.5×
Market median 10.4×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on LLY